US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 0.535
  • +0.019+3.60%
Close Jun 18 16:00 ET
  • 0.519
  • -0.016-3.03%
Post 16:54 ET
19.50MMarket Cap-636P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-28.11%-6.67M
-250.71%-28.71M
-210.02%-8.97M
-366.91%-9.06M
-297.60%-5.48M
-163.49%-5.2M
50.92%-8.19M
19.24%-2.89M
62.16%-1.94M
65.03%-1.38M
Net income from continuing operations
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
56.13%-3.4M
47.78%-3.04M
Depreciation and amortization
--9K
--9K
--6K
----
----
--0
--0
--0
----
----
Other non cash items
----
---131K
----
----
----
----
----
----
----
----
Change In working capital
-108.18%-55K
-123.35%-392K
-446.17%-3.89M
-56.68%240K
457.54%2.59M
245.14%672K
133.19%1.68M
176.00%1.12M
-48.75%554K
-45.60%464K
-Change in prepaid assets
206.59%279K
-429.07%-849K
-182.42%-150K
-335.68%-867K
-67.37%77K
133.33%91K
-78.87%258K
-63.82%182K
-162.38%-199K
-3.67%236K
-Change in payables and accrued expense
-157.49%-334K
-67.84%457K
-497.13%-3.74M
47.01%1.11M
1,000.88%2.51M
215.74%581K
383.63%1.42M
147.53%942K
-1.18%753K
-62.50%228K
Cash from discontinued investing activities
Operating cash flow
-28.11%-6.67M
-250.71%-28.71M
-210.02%-8.97M
-366.91%-9.06M
-297.60%-5.48M
-163.49%-5.2M
50.92%-8.19M
19.24%-2.89M
62.16%-1.94M
65.03%-1.38M
Investing cash flow
Cash flow from continuing investing activities
-6K
47K
-16K
10.03M
-9.97M
0
0
0
0
Net PPE purchase and sale
---6K
---88K
---17K
----
----
--0
--0
--0
----
----
Net investment purchase and sale
----
--135K
--1K
--10.1M
----
----
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
---6K
--47K
---16K
--10.03M
---9.97M
--0
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
-233.33%-8K
240.89%24.68M
-36.36%-75K
233.02%24.78M
78.18%-24K
117.65%6K
16,556.82%7.24M
-41.03%-55K
248,100.00%7.44M
-279.31%-110K
Net common stock issuance
----
242.07%24.73M
-16.36%-64K
----
----
----
--7.23M
---55K
----
----
Proceeds from stock option exercised by employees
33.33%8K
33.33%16K
--1K
--9K
--0
-50.00%6K
-80.65%12K
--0
--0
--0
Net other financing activities
---16K
---60K
---12K
---24K
----
----
----
----
----
---110K
Cash from discontinued financing activities
Financing cash flow
-233.33%-8K
240.89%24.68M
-36.36%-75K
233.02%24.78M
78.18%-24K
117.65%6K
16,556.82%7.24M
-41.03%-55K
248,100.00%7.44M
-279.31%-110K
Net cash flow
Beginning cash position
-9.67%37.13M
-2.25%41.1M
4.85%46.19M
-46.98%20.44M
-10.32%35.9M
-2.25%41.1M
-28.45%42.04M
-3.54%44.05M
-24.11%38.55M
-26.89%40.04M
Current changes in cash
-28.53%-6.68M
-321.08%-3.98M
-207.33%-9.06M
368.13%25.75M
-939.95%-15.46M
-158.74%-5.2M
94.35%-944K
18.59%-2.95M
207.21%5.5M
62.52%-1.49M
End cash Position
-15.20%30.44M
-9.67%37.13M
-9.67%37.13M
4.85%46.19M
-46.98%20.44M
-10.32%35.9M
-2.25%41.1M
-2.25%41.1M
-3.54%44.05M
-24.11%38.55M
Free cash flow
-28.23%-6.67M
-251.79%-28.79M
-210.61%-8.99M
-370.57%-9.13M
-297.60%-5.48M
-163.49%-5.2M
50.92%-8.19M
19.24%-2.89M
62.16%-1.94M
65.03%-1.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -28.11%-6.67M-250.71%-28.71M-210.02%-8.97M-366.91%-9.06M-297.60%-5.48M-163.49%-5.2M50.92%-8.19M19.24%-2.89M62.16%-1.94M65.03%-1.38M
Net income from continuing operations -9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M56.13%-3.4M47.78%-3.04M
Depreciation and amortization --9K--9K--6K----------0--0--0--------
Other non cash items -------131K--------------------------------
Change In working capital -108.18%-55K-123.35%-392K-446.17%-3.89M-56.68%240K457.54%2.59M245.14%672K133.19%1.68M176.00%1.12M-48.75%554K-45.60%464K
-Change in prepaid assets 206.59%279K-429.07%-849K-182.42%-150K-335.68%-867K-67.37%77K133.33%91K-78.87%258K-63.82%182K-162.38%-199K-3.67%236K
-Change in payables and accrued expense -157.49%-334K-67.84%457K-497.13%-3.74M47.01%1.11M1,000.88%2.51M215.74%581K383.63%1.42M147.53%942K-1.18%753K-62.50%228K
Cash from discontinued investing activities
Operating cash flow -28.11%-6.67M-250.71%-28.71M-210.02%-8.97M-366.91%-9.06M-297.60%-5.48M-163.49%-5.2M50.92%-8.19M19.24%-2.89M62.16%-1.94M65.03%-1.38M
Investing cash flow
Cash flow from continuing investing activities -6K47K-16K10.03M-9.97M0000
Net PPE purchase and sale ---6K---88K---17K----------0--0--0--------
Net investment purchase and sale ------135K--1K--10.1M----------0--0--0----
Cash from discontinued investing activities
Investing cash flow ---6K--47K---16K--10.03M---9.97M--0--0--0--0----
Financing cash flow
Cash flow from continuing financing activities -233.33%-8K240.89%24.68M-36.36%-75K233.02%24.78M78.18%-24K117.65%6K16,556.82%7.24M-41.03%-55K248,100.00%7.44M-279.31%-110K
Net common stock issuance ----242.07%24.73M-16.36%-64K--------------7.23M---55K--------
Proceeds from stock option exercised by employees 33.33%8K33.33%16K--1K--9K--0-50.00%6K-80.65%12K--0--0--0
Net other financing activities ---16K---60K---12K---24K-----------------------110K
Cash from discontinued financing activities
Financing cash flow -233.33%-8K240.89%24.68M-36.36%-75K233.02%24.78M78.18%-24K117.65%6K16,556.82%7.24M-41.03%-55K248,100.00%7.44M-279.31%-110K
Net cash flow
Beginning cash position -9.67%37.13M-2.25%41.1M4.85%46.19M-46.98%20.44M-10.32%35.9M-2.25%41.1M-28.45%42.04M-3.54%44.05M-24.11%38.55M-26.89%40.04M
Current changes in cash -28.53%-6.68M-321.08%-3.98M-207.33%-9.06M368.13%25.75M-939.95%-15.46M-158.74%-5.2M94.35%-944K18.59%-2.95M207.21%5.5M62.52%-1.49M
End cash Position -15.20%30.44M-9.67%37.13M-9.67%37.13M4.85%46.19M-46.98%20.44M-10.32%35.9M-2.25%41.1M-2.25%41.1M-3.54%44.05M-24.11%38.55M
Free cash flow -28.23%-6.67M-251.79%-28.79M-210.61%-8.99M-370.57%-9.13M-297.60%-5.48M-163.49%-5.2M50.92%-8.19M19.24%-2.89M62.16%-1.94M65.03%-1.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg